Future growth expectations in earnings/operating earnings/profits/EPS?

Operating margin is expected to improve by approximately 200 basis points (2%) over the next 4 to 8 quarters due to increased sales in higher-margin industrial segments. EBITDA margins have shown robust performance with Q3 FY24 at 19.4% and PAT margins at 10.1%, indicating a positive earnings trajectory. The new Pakhajan plant is expected to ramp up gradually with 50% utilization in FY25, reaching full utilization by FY26, contributing significantly to revenues (~INR 550 crores peak). Vapi plant peak revenue potential is revised to around INR 650 crores (from earlier INR 700-750 crores)

Any current/future new fundraising through debt or equity?

The company’s peak debt is expected to be around INR 500 crores by March 2024, which includes debt for the Pakhajan facility (INR 270 crores), Vapi (INR 30 crores), and working capital (INR 200 crores). The management has confirmed that the working capital debt required to ramp up the Pakhajan plant is already tied up with bankers. They do not foresee the need to raise any equity to fund the Pakhajan plant. There is no mention of additional debottlenecking or further capacity expansions requiring new funding beyond what is already planned and funded. Overall, no new fundraising through equity

Any current/future capex/capital investment/strategic investment?

The Pakhajan plant is a major ongoing capital investment, expected to commence commercial production by the end of March 2024. Peak revenue potential for Pakhajan plant is estimated at INR 550-600 crores based on current prices. Pakhajan plant utilization is expected to be 50% on average in FY25, ramping up to 90% by Q4 FY25 and full utilization in FY26. No further debottlenecking is planned; any capacity increase will come from shifting production to the Pakhajan plant. Working capital debt for the Pakhajan plant is tied up with bankers; no equity raising is planned to fund this capex

Future growth expectations in sales/revenue/volumes?

Volume growth is strong: 21% increase in Q3 FY24 and 5% growth over nine months, indicating an upward business trajectory. Indian market volume growth (~7-8%) outpaces overall growth, expected to increase further with local participation from the new Pakhajan plant. Pakhajan plant is expected to ramp up gradually in FY25 with 50% average utilization, reaching 90% utilization in Q4 FY25 and full utilization in FY26. Peak revenue potential for Pakhajan is estimated at INR 550 crores, while Vapi plant peak revenue is around INR 650 crores given current raw material prices. Operating margins antic

Yasho Industries LtdQ3 FY24Chemicals & Petrochemicals

Yasho Industries Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹3,533.6P/E: 81.5Market Cap: ₹4.3K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Volume growth is strong: 21% increase in Q3 FY24 and 5% growth over nine months, indicating an upward business trajectory.
Indian market volume growth (~7-8%) outpaces overall growth, expected to increase further with local participation from the new Pakhajan plant.
Pakhajan plant is expected to ramp up gradually in FY25 with 50% average utilization, reaching 90% utilization in Q4 FY25 and full utilization in FY26.
Peak revenue potential for Pakhajan is estimated at INR 550 crores, while Vapi plant peak revenue is around INR 650 crores given current raw material prices.
Operating margins anticipated to improve by approximately 200 basis points over the next 4 to 8 quarters due to a better product mix and increased industrial segment sales.
Export markets, especially the US (over 40% of export revenue), remain a key focus with plans to penetrate end-users via local stock points.
Some optimism about price recovery in 2-3 quarters aligned with market demand rebound.

Margin guidance

Category 2

Operating margin is expected to improve by approximately 200 basis points (2%) over the next 4 to 8 quarters due to increased sales in higher-margin industrial segments.
EBITDA margins have shown robust performance with Q3 FY24 at 19.4% and PAT margins at 10.1%, indicating a positive earnings trajectory.
The new Pakhajan plant is expected to ramp up gradually with 50% utilization in FY25, reaching full utilization by FY26, contributing significantly to revenues (~INR 550 crores peak).
Vapi plant peak revenue potential is revised to around INR 650 crores (from earlier INR 700-750 crores) due to raw material price corrections.
Growth is expected from industrial product segments, particularly with a better product mix and strategic market expansion (including US and Europe).
Overall volume growth remains strong with 21% YoY increase in the quarter and 5% increase for nine months.
Management remains optimistic about sustaining profitable growth despite current market challenges.

See what Yasho Industries Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

The company’s peak debt is expected to be around INR 500 crores by March 2024, which includes debt for the Pakhajan facility (INR 270 crores), Vapi (INR 30 crores), and working capital (INR 200 crores).
The management has confirmed that the working capital debt required to ramp up the Pakhajan plant is already tied up with bankers.
They do not foresee the need to raise any equity to fund the Pakhajan plant.
There is no mention of additional debottlenecking or further capacity expansions requiring new funding beyond what is already planned and funded.
Overall, no new fundraising through equity or additional debt beyond the current commitments is planned in the near term.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Yasho Industries Limited. However, some relevant points related to demand and production outlook are: - The Pakhajan plant (new facility) is expected to ramp up gradually with average 50% utilization in FY25, reaching 90% utilization by the last quarter. - There are soft commitments and keen customer interest to support this utilization forecast. - Validation and government approval processes for the new plant are underway, expected to complete in 4-8 weeks. - Indian market demand is robust with a growth of 7-8% volume; exports have been subdued but US and Europe markets are strategic focuses. - US contributes 40% of export revenue, and a US subsidiary was set up for better end-user penetration. - The management projects steady volume growth with industrial segments contributing strongly. No explicit order book figures or pending order values were disclosed in the call.

See what Yasho Industries Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

The Pakhajan plant is a major ongoing capital investment, expected to commence commercial production by the end of March 2024.
Peak revenue potential for Pakhajan plant is estimated at INR 550-600 crores based on current prices.
Pakhajan plant utilization is expected to be 50% on average in FY25, ramping up to 90% by Q4 FY25 and full utilization in FY26.
No further debottlenecking is planned; any capacity increase will come from shifting production to the Pakhajan plant.
Working capital debt for the Pakhajan plant is tied up with bankers; no equity raising is planned to fund this capex.
The company is working on stock points in the US and Europe for better market penetration, hinting at strategic investments in distribution infrastructure.

Track Yasho Industries Ltd — get its next earnings analysis in your feed

How does Yasho Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisYasho Industries Ltd

Rev 3Mar 2

See where Yasho Industries Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Yasho Industries Ltd rank in Chemicals & Petrochemicals?

Compare Yasho Industries Ltd against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Yasho Industries Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

GOCL Corporation Ltd (Q2 FY27)
Year-on-year (YoY) increase in revenue from operations: Approximately 85% increase (41,063 vs. Key results statement takeaways from GOCL Corpn.'s Q2 FY27 result
AksharChem (I) (Q2 FY27)
Year-on-year revenue growth for the quarter is approximately 79.7% [(16,048.24 . Key results statement takeaways from AksharChem (I)'s Q2 FY27 results statement
Bhansali Engineering Polymers Ltd (Q2 FY27)
Revenue from operations (net) for the quarter ended 30/09/2026 is ₹40,336.95 lakhs, compared to ₹32,509.76 lakhs for the quarter ended 30/09/2025, reflecting a…
Tatva Chintan (Q2 FY27)
Q2 FY27 revenue from operations: ₹2,173 Mn, up 76% YoY from ₹1,235 Mn in Q2 FY26 (Page 11). Key investor presentation takeaways from Tatva Chintan's Q2 FY27 inv

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →